Literature DB >> 8771446

A comparison of cognitive profiles in schizophrenia and other psychiatric disorders.

M Mitrushina1, J Abara, A Blumenfeld.   

Abstract

This study compared patients across 5 psychiatric diagnostic groups: Depression, Mania, Schizophrenia, Schizoaffective Disorder, and Psychosis NOS, all of whom are psychotic. Differences in overall cognitive profiles and in dysfunctional memory mechanisms, as well as the effect of psychosis on cognitive functioning were explored using the Neurobehavioral Cognitive Status Examination (NCSE), a brief screening instrument. Results indicated pronounced deficit in memory and abstract reasoning associated with schizophrenic illness, which is not secondary to psychosis and points to localized brain dysfunction. Both encoding and postencoding memory mechanisms were affected. Results support a hypothesis of progressive dysfunction associated with the severity and chronicity of the illness. Implications of findings in aiding diagnostic determination, patient management and rehabilitation are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8771446     DOI: 10.1002/(SICI)1097-4679(199603)52:2<177::AID-JCLP9>3.0.CO;2-R

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  3 in total

1.  Does diagnostic classification of early-onset psychosis change over follow-up?

Authors:  David Fraguas; María J de Castro; Oscar Medina; Mara Parellada; Dolores Moreno; Montserrat Graell; Jessica Merchán-Naranjo; Celso Arango
Journal:  Child Psychiatry Hum Dev       Date:  2007-07-31

2.  Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.

Authors:  Daniel J Abrams; Donald C Rojas; David B Arciniegas
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

3.  Neuropsychological functioning in inpatients with major depression or schizophrenia.

Authors:  Annette Schaub; Nicole Neubauer; Kim T Mueser; Rolf Engel; Hans-Jürgen Möller
Journal:  BMC Psychiatry       Date:  2013-08-02       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.